MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LGND made $115,461K in revenue. $117,273K in net income. Net profit margin of 101.57%.

Income Overview

Revenue
$115,461K
Net Income
$117,273K
Net Profit Margin
101.57%
EPS
$5.68
Unit: Thousand (K) dollars
Revenue Breakdown
    • Contract Revenue And Other Incom...
    • Intangible Royalty Assets
    • Material Sales Captisol
    • Financial Royalty Assets
Revenue Breakdown
    • Income From Divestiture Transact...
    • Kyprolis
    • Material Sales Captisol
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2024-12-31
2024-09-30
2024-06-30
Total revenues and other income
115,461 -51,812 41,531
Cost of captisol
3,801 -2,449 2,906
Amortization of intangibles
8,097 -8,258 8,257
Research and development
21,019 -5,675 5,354
General and administrative
28,446 -24,475 17,623
Financial royalty assets impairment
0 --26,491
Fair value adjustments to partner program derivatives
833 --7,812 -
Total operating costs and expenses
60,530 -48,669 60,631
Operating income (loss)
54,931 -3,324 3,143 -19,100
Gain (loss) from short-term investments
7,798 43,437 2,407 -14,256
Gain (loss) from change in fair value of equity-method investments and other investments
75,887 ---
Interest income
3,874 1,976 1,347 2,757
Interest expense
910 514 741 1,268
Other non-operating expense, net
-443 -4,450 -12,495 -33,523
Total non-operating income (expenses), net
86,206 40,448 -9,482 -46,290
Income (loss) before income taxes
141,137 37,124 -6,339 -65,390
Income tax expense
23,864 9,598 833 -13,479
Net income (loss) from continuing operations
-27,526 -7,172 -51,911
Net income (loss)
117,273 27,526 -7,172 -51,911
Basic net income (loss) per share (in usd per share)
5.99 1.525 -0.39 -2.88
Diluted net income (loss) per share (in usd per share)
5.68 1.525 -0.39 -2.88
Shares used in basic per share calculation (in shares)
19,578,000 -9,078,500 18,419,000 18,028,000
Shares used in diluted per share calculation (in shares)
20,629,000 -9,078,500 18,419,000 18,028,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Financial Royalty Assets$6,425K Intangible Royalty Assets$40,161K Contract Revenue AndOther Income$58,203K Material Sales Captisol$10,672K Royalty$46,586K Interest income$3,874K Gain (loss) fromchange in fair value of...$75,887K Gain (loss) fromshort-term investments$7,798K Total revenues andother income$115,461K Total non-operatingincome (expenses), net$86,206K Operating income (loss)$54,931K Other non-operatingexpense, net-$443K Interest expense$910K Total operating costsand expenses$60,530K Fair valueadjustments to partner...$833K Income (loss) beforeincome taxes$141,137K General andadministrative$28,446K Research and development$21,019K Amortization of intangibles$8,097K Cost of captisol$3,801K Net income (loss)$117,273K Income tax expense$23,864K

LIGAND PHARMACEUTICALS INC (LGND)

LIGAND PHARMACEUTICALS INC (LGND)